ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,163.67
0.00%
Dow Jones
38,647.10
-0.17%
Gold vs US Dollar
2,312.025
0.41%
Brent Oil
82.135
0.20%
Bitcoin
66,900.33
0.21%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Auris Medical Holding AG (EARS)

  7. Auris Medical Holding AG (EARS) News

Auris Medical (EARS)

Auris Medical Holding AG
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EARS
DateTimeSourceHeadlineSymbolCompany
27/06/202321:46Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EARSAuris Medical Holding AG
16/06/202322:02Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1)NASDAQ:EARSAuris Medical Holding AG
15/06/202321:30Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EARSAuris Medical Holding AG
12/06/202311:44Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EARSAuris Medical Holding AG
12/06/202311:43Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EARSAuris Medical Holding AG
09/06/202321:37Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:EARSAuris Medical Holding AG
09/06/202321:36Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:EARSAuris Medical Holding AG
01/06/202321:32Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1)NASDAQ:EARSAuris Medical Holding AG
30/05/202313:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EARSAuris Medical Holding AG
26/05/202322:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EARSAuris Medical Holding AG
16/05/202321:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EARSAuris Medical Holding AG
27/04/202321:34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:EARSAuris Medical Holding AG
18/04/202313:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EARSAuris Medical Holding AG
17/04/202317:22Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)NASDAQ:EARSAuris Medical Holding AG
13/04/202314:05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EARSAuris Medical Holding AG
13/04/202313:20Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:EARSAuris Medical Holding AG
11/04/202321:02Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)NASDAQ:EARSAuris Medical Holding AG
11/04/202321:02Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:EARSAuris Medical Holding AG
03/04/202311:19Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EARSAuris Medical Holding AG
27/03/202315:34Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)NASDAQ:EARSAuris Medical Holding AG
23/03/202312:01Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:EARSAuris Medical Holding AG
23/03/202310:05Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)NASDAQ:EARSAuris Medical Holding AG
09/03/202321:32Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:EARSAuris Medical Holding AG
09/03/202321:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EARSAuris Medical Holding AG
08/03/202315:11Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:EARSAuris Medical Holding AG
28/02/202321:18Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)NASDAQ:EARSAuris Medical Holding AG
16/02/202315:20Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1)NASDAQ:EARSAuris Medical Holding AG
27/01/202313:51Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EARSAuris Medical Holding AG
18/01/202321:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:EARSAuris Medical Holding AG
28/12/202211:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EARSAuris Medical Holding AG
 Showing the most relevant articles for your search:NASDAQ:EARS

Your Recent History

LSE
SCLP
Scancell
LSE
ENET
Ethernity Networks
LSE
GKP
Gulf Keystone Petroleum
LSE
HE1
Helium One Global
LSE
GDR
Genedrive
LSE
LGEN
Legal & General
LSE
LLOY
Lloyds Banking
LSE
TAVI
Tavistock Investments
LSE
ARCM
Arc Minerals
LSE
NFDS
Northern Foods
LSE
CPI
Capita
LSE
RQIH
R&q Insurance
LSE
JEMA
Jpmorgan Emerging Europe...
LSE
AAZ
Anglo Asian Mining
LSE
RBD
Reabold Resources
LSE
MNL
Manchester & London Inve...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved